Verve hires Tom MacIsaac as chief executive ahead of buying Deconstruct Media.

BG Medicine plans to list 4.75 million shares for $7 each at its initial public offering (IPO), although investment bank Lazard can sell a further 712,500 shares if demand is strong enough. The previous price range was $13 to $15 per share.

Fluidigm will offer 5.17 million common shares when it floats on the Nasdaq stock exchange at between $13.50 and $15.50 per share.

New York or Nasdaq could be flotation route for social network LinkedIn after it files for initial public offering

AcelRx will issue 6.6 million shares at up to $14 each to raise $92.9m, including 865,500 shares the investment bank Piper Jaffray can sell if demand is strong enough. After the initial public offering (IPO), AcelRx will have a market capitalisation of up to $230m based on 16.1 million shares in issuance.

The company will sell 7.15 million common shares at its initial public offering (IPO) at between $13 and $15 each, according to Gevo's regulatory filing.

BW and Investinor provide exit for OceanSaver's investors.

Newswire Reuters said a prospectus for LinkedIn's initial public offering was expected to be completed by end-March with the three banks as book-runners selling its shares to the public.

Strategic investors were set to help their Indian mobile services portfolio company One97 float to raise money to buy more telecoms equipment but after an initial deferment until mid-December, the initial public offering has been further delayed until next year.

DangDang made a higher-than-expected $197m through its IPO with existing shareholders selling $56.75m of stock.